Zealand Pharma and Roche to advance petrelintide, an amylin analog, to Phase 3 trials for chronic weight management
Company announcement – No. 11 / 2026 Zealand Pharma and Roche to advance petrelintide, an amylin analog, to…
Exclusive | Anthropic Adds Novartis CEO to Board
Anthropic has appointed Vas Narasimhan, chief executive of Swiss pharmaceutical company Novartis NOVN 0.56%increase; green up pointing triangle,…
How an Office Romance Sparked an Overhaul at Nestlé
An office romance at Nestlé NESN -0.29%decrease; red down pointing triangle cost the chief executive his job. Now…
UBS Wins U.S. National Charter: Broadening Services for Wealth Management Clients
UBS is set to transform its U.S. entity, UBS Bank USA, into a nationally chartered bank following approval…
UBS Asset Management Bolsters China Equities Team with Former Invesco Pro, Raymond Ma
UBS Asset Management has recently augmented its China equities team with the addition of Raymond Ma, a veteran…
Swiss Rockets acquires Complete Genomics
Basel-based biotech group Swiss Rockets has acquired U.S. life sciences company Complete Genomics. The acquisition will strengthen Swiss…
Japanese chemical group chooses Zurich as hub for Physical AI investments
DIC Corporation, a globally leading fine chemicals company, is launching a USD 62 million investment platform to back…
OWP Lausanne 2026 – IMD Business School
Returning to OWP for the 10th time, Jean-Frederic Guinot, CEO of Farinia Group, explains how the yearly learning…
UBS Taps 30-Year Veteran Andrew Bird to Spearhead Australian Wealth Management Division
UBS, the multinational investment bank and financial services company, recently declared the appointment of Andrew Bird as its…
The firing of Nestlé’s CEO and the new rules of office romance
Last week, Nestlé, the $244 billion food conglomerate behind some of the world’s most beloved candy and coffee…